Methimazole-induced aplastic anemia in third exposure: Successful treatment with recombinant human granulocyte colony-stimulating factor

Thyroid

Volumn 8, Issue 9, 1998, Pages 791-794

  Mezquita, P ^a   Luna, V ^a   Munoz Torres M ^a,b   Torres Vela, E ^a   Lopez Rodriguez, F ^a   Callejas, J L ^a   Escobar Jimenez, F ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THIAMAZOLE;

ADULT; AGRANULOCYTOSIS; APLASTIC ANEMIA; ARTICLE; BLOOD CELL COUNT; CASE REPORT; FEMALE; GRAVES DISEASE; HEMOLYTIC ANEMIA; HUMAN; HYPOPROTHROMBINEMIA; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTOPENIA;

EID: 0031728625     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.1998.8.791     Document Type: Article

References (31)

1. Mackenzie JB, Mackenzie CG, McCollum EV 1941 The effect of sulfanilylguanidine on the thyroid of the rat. Science 94:518-519.
2. Cooper DS 1984 Antithyroid drugs. N Engl J Med 311:1353-1362.
3. Reinwein D, Benker G, Lazarus JH, Alexander WD, and The European Multicenter Study Group on Antithyroid Drug Treatment 1993 A prospective randomized trial of antithyroid drug dose in Grave's disease therapy. J Clin Endocrinol Metab 76:1516-1521.
4. Meyer-Gebner M, Benker G, Lederbogen S, Olbricht T, Reinwein D 1994 Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature. J Endocrinol Invest 17:29-36.
5. Tajiri J, Noguchi S, Murakami T, Murakami N 1990 Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring. Arch Intern Med 150:621-625.
6. Tamai H, Takaichi Y, Morita T, Komaki G, Matsubayashi S, Kuma K, Walter RM, Kumagai LF, Nagataki S 1989 Mathimazole-induced agranulocytosis in Japanese patients with Graves' disease. Clin Endocrinol 30:525-530.
7. Biswas N, Ahn YH, Goldman JM, Schwartz JM 1991 Aplastic anemia associated with antithyroid drugs. Am J Med Sci 301:190-194.
8. Tamai H, Mukuta T, Matsubayashi S, Fukata S, Komaki G, Kuma K, Kumagai LF, Nagataki S 1993 Treatment of methimazole-induced agranulocytosis using recombinant human granulocyte colony-stimulating factor. J Clin Endocrinol Metab 77:1356-1360.
9. Tajiri J, Noguchi S, Okamura S, Morita M, Tamaru M, Murakami N, Niho Y 1993 Granulocyte colony-stimulating fac-tor treatment of antithyroid drug-induced granulocytopenia. Arch Intern Med 153:509-514.
10. Magner JA, Snyder DK 1994 Methimazole-induced agranulocytosis treated with recombinant human granulocyte colony-stimulating factors. Thyroid 4:295-296.
11. Moroni M, Tommaselli F, Casagranda I, Rizzi E, Porta C 1995 Methimazole agranulocytosis treated with recombinant human granulocyte colony-stimulating factor. Rec Prog Med 86:241.
12. Lopez Karpovitch X, Ulloa Aguirre A, Von Eiff C, Hurtado Monroy A, Alania A 1992 Treatment of methimazole-induced secondary aplastic anemia with recombinant human granulocyte-monocyte colony-stimulating factor and glucocorticosteroids. Acta Haematol 87:148-150.
13. Escobar-Morreale HF, Bravo P, Garcia-Robles R, Garcia-Laraña J, De la Calle H, Sancho JM 1997 Methimazole-induced severe aplastic anemia: Unsuccessful treatment with recombinant human granulocyte-monocyte colony-stimulating factor. Thyroid 7:67-70.
14. Martelo OJ, Katims RB, Yunis AA 1967 Bone marrow aplasia following propylthiouracil therapy. Arch Intern Med 120:587-590.
15. Aksoy M, Erdem S 1968 Aplastic anemia after propylthiouracil. Lancet 1:1379.
16. Edell SL, Bartuska DG 1975 Aplastic anemia secondary to methimazole. J Am Med Womens Assoc 30:412-413.
17. Herrera Pombo JI, Cordido F, Vazquez C, Sanchez Fayos J 1987 Aplastic pancytopenia caused by antithyroid drugs. Rev Clin Exp 181:168.
18. Kobayashi T, Ishiguro A, Andoh O, Tsuji K, Naganuma K, Yagi Y, Nakahata T, Akabane T 1987 A case of drug-induced secondary aplastic anemia. Rinsho Ketsueka 28:1587-1592.
19. Moreb J, Shemesh O, Shilo S, Manor C, Hershko C 1983 Transient methimazole-induced bone marrow aplasia: In vitro evidence for a humoral mechanism of bone marrow suppression. Acta Haematol 69:127-131.
20. Wall JR, Fang SL, Kuroki T, Ingbar SH, Braverman LE 1984 In vitro immunoactivity to propylthiouracil, methimazole and carbimazole in patients with Graves' disease: A possible cause of antithyroid drug-induced agranulocytosis. J Clin Endocrinol Metab 58:868-872.
21. Douer D, Eisenstein Z 1988 Methimazole-induced agranulocytosis: Growth inhibition of myeloid progenitor cells by the patient's serum. Eur J Haematol 40:91-94.
22. Tamai H, Sudo T, Kimura A, Mukuta T, Matsubayashi S, Kuma K, Nagataki S, Sasazuki T 1996 Association between the DRB1*08032 histocompatibility antigen and mathimazole-induced agranulocytosis in Japanese patients with Graves' disease. Ann Intern Med 124:490-494.
23. Young NS, Maciejewski J 1997 The pathophysiology of acquired aplastic anemia. New Engl J Med 336:1365-1372.
24. Werner MC, Romaldini JH, Bromberg N, Werner RS, Farah CS 1989 Adverse effects related to thionamide drugs and their regimen dosage. Am J Med Sci 297:216-219.
25. Romaldini JH, Werner MC, Bromberg N, Werner RS 1991 Adverse effects related to thionamide drugs and their regimen dosage. Exp Clin Endocrinol 97:261-264.
26. Smith CA, Spooncer E, Dexter TM, Taylor DR 1990 Haematopoietic colony stimulation factors promote cell survival by suppressing apoptosis. Nature 343:76-79.
27. American Society of Clinical Oncology 1996 Update of recommendations for the use of haematopoietic colony-stimulating factors: Evidence-based clinical practice guidelines. J Clin Oncol 14:1957-1960.
28. Pui CH, Boyett JM, Hughes WT, Rivera GK, Hancock ML, Sandlund JT, Synold T, Relling MV, Ribeiro RC, Grist WM, Evans WE 1997 Human granulocyte colony-stimulating factor after induction chemotherapy in children with acute lymphoblastic leukemia. N Engl J Med 336:1781-1787.
29. Hartmann LG, Tschetter LK, Habermann TM, Ebbert LP, Johnson PS, Mailliard JA, Levitt R, Suman VJ, Witzig TE, Wieand HS, Miller LL, Moertel CG 1997 Granulocyte colony-stimulating factor in severe chemotherapy-induced febrile neutropenia. N Engl J Med 336:1776-1780.
30. Rossi C, Klasterky J 1996 INitial empirical antibiotic therapy for neutropenic fever: analysis of the cause of death. Support Care Cancer 4:207-212.
31. Willfort A, Lorber C, Kapiotis S, Serti S, Hainz R, Kirchweger P, Jager U, Kyrie PA, Lechner K, Geissler K 1993 Treatment of drug-induced agranulocytosis with recombinant granulocyte colony-stimulating factor. Ann Hematol 66:241-244.